We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SF:NYSEStifel Financial Corporation Analysis

Data as of 2026-07-08 - not real-time

$73.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Stifel Financial Corp. is trading well below its discounted cash‑flow estimate, offering a material upside potential. Its price‑to‑earnings multiple sits comfortably under the industry average, indicating relative undervaluation. The company posted double‑digit revenue growth, underscoring strong top‑line momentum. Gross margin remains exceptionally high, reflecting efficient cost control. Operating margin is solid, supporting robust profitability. Return on equity is healthy, evidencing effective capital deployment. Dividend payout is modest, bolstering the sustainability of the current yield. The balance sheet shows ample cash relative to debt, providing a comfortable liquidity cushion. Technical indicators reveal a bullish MACD crossover despite a broader bearish price trend. RSI is neutral, suggesting further upside room. Average daily volume is rising, indicating improving liquidity. Analyst consensus remains a buy.
Given the combination of attractive valuation, solid fundamentals, and supportive technical signals, the stock presents a compelling case for investors seeking both income and growth. The modest payout ratio and strong cash position enhance dividend reliability, while the revenue growth trajectory positions the firm well for future earnings expansion.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical bullish MACD signal despite bearish trend
  • Current price well below DCF fair value
  • Sustainable dividend with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high gross margins
  • Robust cash position relative to debt
  • Continued earnings accretion supporting forward earnings multiple

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term undervaluation relative to peers
  • Stable dividend and solid balance sheet
  • Diversified wealth management and institutional franchise

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin15.56%
P/E Ratio14.3
ROE15.31%
ROA2.12%
Debt/Equity41.53
P/B Ratio2.1
Op. Cash Flow$985.7M
Industry P/E17.4

Technical Analysis

TrendBearish
RSI52.7
Support$67.81
Resistance$75.74
MA 20$72.37
MA 50$73.29
MA 200$77.79
MACDBullish
VolumeIncreasing
Fear & Greed Index91.25

Valuation

Fair Value$127.80
Target Price$86.75
Upside/Downside18.33%
GradeUndervalued
TypeBlend
Dividend Yield1.73%

Risk Assessment

Beta1.07
Volatility26.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.